Discontinuation report ACT LEVETIRACETAM

Last updated on 2020-01-24 History
Report ID 104304
Drug Identification Number 02274191
Brand name ACT LEVETIRACETAM
Common or Proper name ACT-LEVETIRACETAM 500MG FC TAB
Company Name TEVA CANADA LIMITED
Market Status MARKETED
Active Ingredient(s) LEVETIRACETAM
Strength(s) 500MG
Dosage form(s) TABLET
Route of administration ORAL
Packaging size 100
ATC code N03AX
ATC description ANTIEPILEPTICS
Reason for discontinuation Business reasons
Anticipated discontinuation date
Actual discontinuation date 2019-12-05
Remaining supply date 2019-12-05
Discontinuation status Discontinued
Discontinuation decision reversal No
Information on remaining supply
Company comments
Health Canada comments
Contact Address 30 NOVOPHARM COURT
TORONTO, ONTARIO
CANADA M1B 2K9
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v2 2020-01-24 French Compare
v1 2020-01-24 English Compare